Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients

The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Crispr (DNA), CRISPR Therapeutics, Drugs (Pharmaceuticals), Food and Drug Administration, Genetic Engineering, Sickle Cell Anemia, Vertex Pharmaceuticals Inc
←How Britney Spears Wrote ‘The Woman in Me’
Mitt Romney And Wife’s Travis Kelce, Taylor Swift Halloween Costumes Are Truly Chilling→

More posts

  • Lehmann again denies knowing about sandpaper plot

  • The real reason Senate leaders keep becoming incredibly unpopular

  • Hailey Bieber’s It-Jacket Wardrobe Is Becoming Untenable

  • Reading in Reverse

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube